| Toxicity | HPV+ | HPV− |
| Mucositis |
|
|
| Grade 0 | 5.9% | 6.3% |
| Grade 1 | 11.8% | 12.5% |
| Grade 2 | 41.2% | 41.7% |
| Grade 3 | 35.3% | 33.3% |
| Grade 4 | 5.9% | 6.3% |
| Xerostomia |
|
|
| Grade 1 | 11.8% | 10.4% |
| Grade 2 | 52.9% | 56.3% |
| Grade 3 | 29.4% | 25.0% |
| Grade 4 | 5.9% | 8.3% |
| Dermatitis |
|
|
| Grade 0 | 5.9% | 6.3% |
| Grade 1 | 11.8% | 12.5% |
| Grade 2 | 41.2% | 41.7% |
| Grade 3 | 35.3% | 33.3% |
| Grade 4 | 5.9% | 6.3% |